GlassScriptPhysician profile
Lionel Thomas
NPI 1225483035
$1,272.43
in general payments reported to CMS, 2019-2025
18 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $128 · 2021: $53.28 · 2022: $35.08 · 2023: $135 · 2024: $165 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.74 | 2019-2024 | Duopa, Botox |
| Medtronic, INC. | $225.11 | 2025 | Percept PC Brainsense |
| Ucb, INC. | $130.62 | 2024-2025 | Fintepla, Nayzilam |
| Amgen INC. | $117.93 | 2019-2020 | |
| Eisai INC. | $66.76 | 2020-2021 | |
| Sk Life Science, INC. | $66.46 | 2025 | |
| Mallinckrodt Enterprises LLC | $46.64 | 2019 | |
| Tanabe Pharma America, INC. | $39.68 | 2019 | |
| Acorda Therapeutics, INC | $38.56 | 2019 | |
| Neurelis, INC. | $32.63 | 2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $24.89 | 2019 | |
| Akcea Therapeutics, INC. | $20.20 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.29 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.41 | 2020 | |
| Adamas Pharmaceuticals, INC. | $15.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $15.01 | 2019 | |
| Lundbeck LLC | $12.67 | 2019 | |
| Saol Therapeutics INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lionel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.